Plain-English translation of NCT06486428 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a new way to involve people with small cell lung cancer in research — by letting them participate from home instead of traveling to a clinic. Researchers want to see if they can successfully collect blood samples and medical information remotely from patients across the United States. This approach could make it easier for patients to contribute to lung cancer research without the burden of frequent hospital visits.
Many patients with small cell lung cancer face challenges participating in research because of travel demands, treatment side effects, or limited access to research centers. This study aims to remove those barriers by offering a decentralized approach, so more patients can help advance lung cancer care and understanding.
You would contact the study team through a website form or phone hotline to enroll. At home, you'll provide a blood sample (using a collection kit sent to you), complete an initial survey about your diagnosis and treatment, and share your medical records with the research team. You'll then complete a follow-up survey 3 months later. The entire process takes place remotely — no clinic visits required.
AI-generated summary from trial data · Aug 17, 2026 · Not medical advice
United States